期刊文献+

急性心肌梗塞循环内皮祖细胞与冠状动脉病变严重程度的分析 被引量:3

Correlation between level of circulating endothelial progenitor cells and severity of coronary artery disease in patients with acute myocardial infarction
下载PDF
导出
摘要 目的:研究急性心肌梗塞(AMI)患者外周血中内皮祖细胞(EPCs)的水平与冠状动脉病变程度之间的关系。方法:选取55例AMI患者,以定量冠状动脉造影评估冠状动脉的血管狭窄程度,同时选取30名冠状动脉造影阴性的患者为对照组。所有患者均在入院后即刻[AMI发病平均时间(2.5±1.5)h],第24h、48h、72h、7d、14d及一个月时采血,以CD133作为EPCs标记物,用流式细胞仪检测患者外周血中CD133标记细胞数量。结果:AMI组患者及对照组均有EPCs(CD133)的表达,AMI患者EPCs数目明显低于非冠心病患者(P<0.05)。多支病变者较单支病变者有降低趋势,但无显著性差异(P>0.05)。EPCs数目和Gensini评分呈明显负相关(n=55,r=-0.619,P<0.05)。结论:急性心肌梗塞患者EPCs数目和冠状动脉病变程度有关。 Objective: To research the correlation between level of circulating endothelial progenitor cells and severity of coronary artery disease in patients with acute myocardial infarction. Methods: A total of 55 acute myocardial infarction (AMI) patients who underwent coronary angiography were enrolled. The coronary vascular stenosis was evaluated with quantitative coronary angiography. At the same time the 30 patients with normal coronary angiography were regard as control group. All patients were bled immediately [AMI average time of (2.5±1.5) h] , on 24 h, 48 h, 72 h, 14 d and one month. EPC was marked by CD133, and flow cytometry was used to detect cell marked with CD133. Results: EPCs (CD133) were both expressed in peripheral blood of AMI patients and control group. The number of EPCs in AMI patients was significantly lower than that of non-coronary heart disease (P〈 0.05). The number of EPCs in patients with multi-vessel disease was lower than that with single-vessel disease, but it did not reach statistical difference (P〉 0. 05). The number of EPCs was clearly negative correlation with Gensini score (n = 55, r=0. 619, P〈0.05). Conclusion: Number of EPCs are correlated with the extent of coronary artery disease in patients with acute myocardial infarction.
作者 张敬 曲鹏
出处 《心血管康复医学杂志》 CAS 2009年第5期433-436,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 内皮 干细胞 心肌梗塞 冠状血管造影术 Endothelium Stem cells Myocardial infarction Coronary angiography
  • 相关文献

参考文献14

  • 1Hur J, Yoon CH, Kim HS, et al. Characterization of two types of endothelial progenitor ceils and their different contributions to neovasculogenesis [J]. Arterioscler Thromb Vase Biol, 2004, 24: 288-293.
  • 2杜爱玲,姚荣国,孙金红.血管内皮细胞生长因子与冠心病侧支循环的关系[J].心血管康复医学杂志,2005,14(1):19-21. 被引量:13
  • 3Untergasser G, Koeck R, Wolf D, et al. CD34+/CD133-circulating endothelial precursor cells (CEP) : Characterization, senescence and in vivo application [J]. Exp Gerontol, 2006, 41 (6):600-608.
  • 4Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined: a consensus document of the joint European society of cardiology/American college of cardiology committee for the redefinition of myocardial infarction [J]. J Am Coll Cardiol,2000, 36: 959.
  • 5Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease [J]. Am J Cardiol, 1983, 51: 606.
  • 6Vasa M, Fichtlscherer S, Aicher, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease [J]. Cire Res, 2001, 89 (1): E1-7.
  • 7Hill JM, Zalos G, Halcox JP, et al. Circulation endothelial progenitor cells, vascular funtion and cardiovaslar risk [J]. N Engl J Med, 2003, 348 (7): 593-600.
  • 8汪海娅,高平进,姬开达,沈卫峰,陆林,朱鼎良.稳定性冠心病患者循环内皮祖细胞与冠状动脉病变严重程度的分析[J].中华心血管病杂志,2005,33(5):425-427. 被引量:13
  • 9Walter DH, Rittig K, Bahlmana FH, et al. Statin therapy accelerates reendothelialzation: a novel effect involving mobization and incorporation of bone marrow derived endothelial progenitor cells [J]. Circulation, 2002, 105 (25): 3017-3024.
  • 10Assmus B, Urbrich C, Aicher A, et al. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes [J]. CireRes, 2003, 92 (9): 1049-1055.

二级参考文献18

  • 1Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science,1997,275:964-967.
  • 2Jonathan M, Gloria Z, Julian PJ, et al. Circulating endothelial progenitor cells, vascular function and cardiovascular risk. N Engl J Med, 2003,348:593-600.
  • 3Fan CL, Li Y, Gao PJ, et al. Differentiation of endothelial progenitor cells from human umbilical cord blood CD 34+ cells in vitro. Acta Pharmacol Sin, 2003,24:212-218.
  • 4Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol, 1983,51:606.
  • 5Vasa M, Fichtlscherer S, Aicher A, et al. number and migratory activity of circulating endothelial rogenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res, 2001,89:E1-E7.
  • 6Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A, 2000,97:3422-3427.
  • 7Murohara T, Ikeda H, Duan J, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest, 2000,105:1527-1536.
  • 8Rosenzweig A. Endothelial progenitor cells. N Engl J Med, 2003,348:581-582.
  • 9Dimmeler S, Zeiher AM. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J Mol Med, 2004,82:671-677.
  • 10Yin AH, Miraglia S, Zanjani ED, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood, 1997, 90:5002-5012.

共引文献24

同被引文献17

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部